Literature DB >> 10382960

Multicentre European study comparing selection techniques for the isolation of CD34+ cells.

E A de Wynter1, D Ryder, F Lanza, G Nadali, H Johnsen, P Denning-Kendall, B Thing-Mortensen, F Silvestri, N G Testa.   

Abstract

Primitive haemopoietic cells are required for studies in both the clinical and research fields and a number of systems have been developed to facilitate isolation of these haemopoietic cell populations. We have analysed the results from several European centres using positive selection of CD34+ cells from haemopoietic tissues (n = 110). Four selection techniques including immunoaffinity columns (Ceprate LC), immunomagnetic beads (Dynabeads, Baxter Isolex 50) and submicroscopic magnetic beads (MACS) were used and the selected CD34+ cells were assessed for purity, yield and enrichment of colony-forming cells (CFC). The mean purities for all samples ranged from 68.4-78.4% for MACS, 33.9-69.9% for Dynabeads, 46.9-66.8% for Ceprate LC and 43.2-65% for Baxter Isolex 50. Yields were variable with all techniques. On average CFC enrichment using the immunoaffinity columns was greater than that observed for the other systems. Some techniques appear to be problematic and may require further expertise to improve the results. Nevertheless, the study demonstrates that highly purified CD34+ cells can be isolated from various haemopoietic sources, though yield and CFC enrichment varies significantly depending on the technique selected. This extends our previous report indicating that not all selection methods generate similar results and that there are differences in the purity, number and colony-forming ability of the cells recovered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382960     DOI: 10.1038/sj.bmt.1701789

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

Review 1.  Overview of T-cell depletion in haploidentical stem cell transplantation.

Authors:  Nicola Daniele; Maria Cristina Scerpa; Maurizio Caniglia; Chiara Ciammetti; Cecilia Rossi; Maria Ester Bernardo; Franco Locatelli; Giancarlo Isacchi; Francesco Zinno
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

Review 2.  How do I perform hematopoietic progenitor cell selection?

Authors:  Scott T Avecilla; Cheryl Goss; Sharon Bleau; Jo-Ann Tonon; Richard C Meagher
Journal:  Transfusion       Date:  2016-02-25       Impact factor: 3.157

3.  CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.

Authors:  Håkan Norell; Yi Zhang; James McCracken; Telma Martins da Palma; Aaron Lesher; Yueying Liu; Jeffrey J Roszkowski; Anquanette Temple; Glenda G Callender; Timothy Clay; Rimas Orentas; José Guevara-Patiño; Michael I Nishimura
Journal:  Cancer Immunol Immunother       Date:  2010-01-06       Impact factor: 6.968

4.  Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Xiaoran Liu; Yangli Liu; Xinyan Huang; Gengpeng Lin; Canmao Xie
Journal:  Mol Med Rep       Date:  2017-08-16       Impact factor: 2.952

Review 5.  Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.